Biomarker identified in relation to pazopanib in refractory urothelial cancer
13 Apr 2012
Biomarker identified in relation to pazopanib in refractory urothelial cancer
Effects of vitamin D on prostate cancer
Mouse models of metastatic breast cancer
Advanced breast cancer consensus and the latest on triple negative breast cancer
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond
FLIMS workshop and management of triple negative breast cancer
ECCO and cancer care in Europe
Managing HER2 overexpression in breast cancer
Debate on the success of breast cancer screening programmes
Analysis of thirty years of clinical trial data
Recent advances in multiple myeloma therapy
Recent advances in non-Hodgkin’s lymphoma therapy